Hypercapnic encephalopathy syndrome: a new frontier for non-invasive ventilation?

Area of Science:

• Pulmonology
• Critical Care Medicine
• Respiratory Medicine

Background:

• Classical guidelines contraindicate non-invasive ventilation (NIV) in hypercapnic encephalopathy syndrome (HES) due to patient compliance and aspiration risks.
• Conventional mechanical ventilation (CMV) is considered the gold standard for HES, despite a lack of controlled data comparing it to NIV.
• Patients with altered mental status are typically excluded from NIV trials in hypercapnic acute respiratory failure.

Purpose of the Study:

• To review the physiologic rationale for using NIV in HES.
• To assess the clinical feasibility of NIV as a first-line strategy in HES.
• To discuss the remaining questions regarding NIV use in HES.

Main Methods:

• This is a review article, synthesizing existing literature and clinical evidence.
• It examines the physiological basis and practical application of NIV in HES patients.
• The review considers data from recent studies on cautious NIV trials in selected HES patients.

Main Results:

• Recent studies suggest that a cautious initial trial of non-invasive positive pressure ventilation (NPPV) may be feasible in selected HES patients.
• This approach requires careful patient selection, experienced caregivers, and close monitoring.
• Endotracheal intubation (ETI) must be readily available as a backup.

Conclusions:

• NIV may be a viable first-line ventilatory strategy for carefully selected HES patients.
• This approach requires a highly monitored setting and experienced medical staff.
• Further research is needed to fully establish the role and safety of NIV in HES.